首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1576953

側流讀取/化驗 - 市場考察，競爭情形，市場預測(2030年)

Lateral Flow Readers/Assays - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球側流讀取/分析市場規模為86.4億美元，預計2030年將達到121.5億美元，預測期間2024-2030年複合年增長率為5.41%。由於愛滋病毒、乙型肝炎、丙型肝炎和流感等傳染病患者數量的增加，以及各大公司創新新產品的推出，該市場呈現顯著增長，預計從 2024 年將增加到2030年。推動該時期整體市場成長的主要因素。

側流讀取/偵測市場動態

根據世界衛生組織（WHO）2024年的公告，2022年全球約有3,900萬人感染愛滋病毒。該文件還指出，大約有 3750 萬人是成年人（15 歲以上），大約 150 萬人是 15 歲以下的兒童。傳染病診斷對於識別 HIV 感染並實現早期檢測、治療監測和傳播預防至關重要。側向層析閱讀器/檢測是 HIV 診斷的重要工具，可快速、即時檢測 HIV 抗體和抗原。能夠及早發現感染，以便及時介入和治療監測。

根據世界衛生組織（2024）數據，2022年全球將有3.04億人感染B型/C型肝炎。側向層析閱讀器/檢測用於透過檢測血液或血清樣本中的特定抗原或抗體來快速有效地診斷乙型/丙型肝炎。這些測試可以在護理點快速提供結果，從而能夠及早發現和監測感染，特別是在資源有限的環境中。

此外，市場參與者推出創新新產品正在提高同類產品的市場佔有率。例如，2023年2月，賽默飛在印度推出了用於傳染病檢測的即時PCR試劑盒。 Applied Biosystems 的TaqPath PCR 試劑盒用於分析多重抗藥性結核病(MDR-TB)、結核分枝桿菌複合體(MTB)、乙型肝炎(HBV)、C型肝炎(HCV)、HIV 和HLA -B27 等基因旨在為診斷的開發和測試提供可靠性和信心。

因此，在 2024-2030 年預測期內，所有上述因素的交互作用預計將推動側流讀數儀/檢測市場的發展。

然而，開發準確的診斷測試和設備、替代程序的可用性等方面的課題可能會限制側流讀取器/分析市場的成長。

側向層析閱讀器/分析市場區隔分析

在側流讀取器/檢測市場的產品領域中，試劑盒和試劑類別預計將在 2023 年佔據主要收入佔有率。側流讀數器/檢測試劑盒和試劑的快速增長是由於其廣泛使用的方法提供了多種獨特的功能和優點，使它們成為首選。

這些試劑盒通常包括側流測試條、樣品製備試劑，有時還包括進行測定所需的緩衝液和稀釋劑。這些試劑盒和試劑具有簡單、方便和多功能的特點。它專為護理點使用而設計，不需要複雜的測試基礎設施，非常適合在診所、醫院甚至家庭診斷等各種環境中進行快速測試。

側流試劑盒和試劑的主要特點是能夠檢測特定的生物標記、抗原或抗體，可用於診斷傳染病（COVID-19、HIV、瘧疾等）、診斷性慢性病（如糖化血紅素）適用於監測心臟事件（例如檢測糖尿病）和評估心臟事件（例如檢測心臟病發作病例中的肌鈣蛋白水平）。此外，這些套件通常針對特定目標進行預先配置，這意味著它們對於所測試的條件具有高度特異性。然而，靈敏度可能因所用試劑的設計和品質而異。

因此，由於上述因素，對試劑盒和試劑類別的需求將激增，因此，在2024-2030 年預測期內，該類別預計將出現相當大的增長，並增加對側向層析讀取器/檢測的需求. 為整體市場成長做出貢獻。

本報告提供全球側流讀取/化驗市場相關調查分析，提供各地區市場規模與預測，過去3年的產品/技術開發，市場主要企業，未來的機會等資訊。

Lateral Flow Readers/Assay Market by Product (Readers [Bench-top Readers, Digital/Mobile Readers], and Kits & Reagents), Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, and Others], Drug Development & Quality Testing, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the growing instances of infectious diseases and rising product developmental activities worldwide

The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030. The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market Dynamics:

As per the World Health Organization (WHO) 2024, nearly 39 million people were living with HIV infection in 2022, globally. The source also stated that nearly 37.5 million were adults (aged 15 and above) and approximately 1.5 million people were children, aged less than 15 years. Infectious disease diagnostics are crucial in identifying HIV infection, enabling early detection, treatment monitoring, and preventing transmission. Lateral flow readers/assays are essential tools in HIV diagnostics, offering rapid, point-of-care detection of HIV antibodies or antigens. They enable early identification of infection, allowing for timely intervention and treatment monitoring.

Data from the WHO 2024, stated that 304 million people were infected by hepatitis B and C across the world in the year 2022. The same source further stated that out of these 254 million were afflicted by hepatitis B and 50 million were affected by hepatitis C. Lateral flow readers/assays are used to quickly and efficiently diagnose hepatitis B and C by detecting specific antigens or antibodies in blood or serum samples. These tests provide rapid results at the point of care, enabling early detection and monitoring of infections, particularly in resource-limited settings.

Additionally, the introduction of new and innovative products by market players are pushing forward the market share for same. For example, in February 2023, Thermo Fisher introduced real-time PCR kits in India for the detection of infectious diseases. The Applied Biosystems TaqPath PCR kits are designed to provide confidence and reliability in diagnostic development and testing for conditions like Multi-Drug Resistant Tuberculosis (MDR-TB), M. Tuberculosis complex (MTB), Hepatitis B (HBV), Hepatitis C (HCV), HIV, and for genetic analysis such as HLA-B27.

Hence, the interplay of all the above-mentioned factors is expected to drive the lateral flow readers/assay market during the given forecast period from 2024 to 2030.

However, challenges in the development of accurate diagnostic tests and equipment, and the availability of alternative procedures, among others may restrict the market growth for the lateral flow readers/assay market.

Lateral Flow Readers/Assay Market Segment Analysis:

In the product segment of the lateral flow readers/assay market, the kits & reagents category is expected to have a significant revenue share in the year 2023. The rapid growth of the kits & reagents of lateral flow readers/assay is due to its widely utilized approach that offers several distinctive features and benefits, making it a preferred option for people.

These kits typically include the lateral flow test strips, reagents for sample preparation, and sometimes buffers or diluents necessary for running the assay. The distinctive features of these kits and reagents lie in their simplicity, convenience, and versatility. Designed for point-of-care use, they do not require complex laboratory infrastructure, which makes them ideal for rapid testing in various settings such as clinics, hospitals, and even home diagnostics.

A key feature of lateral flow kits and reagents is their ability to detect specific biomarkers, antigens, or antibodies, making them suitable for diagnosing infectious diseases (such as COVID-19, HIV, or malaria), monitoring chronic conditions (like diabetes through glycated hemoglobin detection), and assessing cardiac events (e.g., detecting troponin levels in heart attack cases). Moreover, these kits are typically pre-configured for a specific target, meaning they are highly specific to the condition being tested for. However, sensitivity can vary depending on the design and quality of the reagents used.

Therefore, owing to the factors mentioned earlier, the demand for the kits & reagents category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall lateral flow readers/assay market:

Among all the regions, North America is estimated to hold a significant revenue share in the lateral flow readers/assay market. This domination is due to the growing burden of infectious diseases including tuberculosis, outbreaks of influenza, emerging pathogens, growing product developmental activities, presence of key manufacturers, among others that are expected to fuel the lateral flow readers/assay market in the region during the forecast period from 2024 to 2030.

Public Health Agency of Canada (2024), stated that in 2022, there were 1,971 active tuberculosis cases in Canada. Lateral flow readers/assays are used in tuberculosis diagnostics to provide rapid, point-of-care detection of TB antigens or antibodies. These tests help identify active TB cases by detecting Mycobacterium tuberculosis-specific proteins, aiding in early diagnosis and timely treatment.

Advancements in technology, such as the development of rapid diagnostic tests and molecular assays, enhance the accuracy and speed of diagnoses, making testing more accessible. The increase in point-of-care testing is also contributing to the market, allowing immediate results in clinical settings.

Rising product developmental activities by regulatory bodies in the region are likely to push forward the revenue shares for the same. For example, in November 2023, Abbott announced that it received the U.S. Food and Drug Administration (FDA) approval for its human papillomavirus or HPV screening solution.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market key players:

Some of the key market players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

Recent Developmental Activities in the Lateral Flow Readers/Assay Market:

In January 2021, LumiraDx announced multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test was made available to patients in more than 30 nations worldwide.
In January 2021, ADS Biotec announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company obtained a CE mark for the industry's first Rapid Antigen Test that works with both nasal swabs and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.

Key takeaways from the Lateral Flow Readers/Assay market report study

Market size analysis for current lateral flow readers/assay market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the lateral flow readers/assay market
Various opportunities available for the other competitors in the lateral flow readers/assay market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current lateral flow readers/assay market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for lateral flow readers/assay market growth in the coming future?

Target audience who can be benefited from this Lateral Flow Readers/Assay market report study

Lateral flow readers/assay device providers
Research organizations and consulting companies
Lateral flow readers/assay related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in lateral flow readers/assay
Various end-users who want to know more about the lateral flow readers/assay market and the latest developments in the lateral flow readers/assay market

Frequently Asked Questions for the Lateral Flow Readers/Assay Market:

1. What are Lateral Flow Readers/Assay?

The lateral flow readers/assay are simple diagnostic devices that are used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. The most commonly known type of lateral flow rapid test strip is the pregnancy test.

2. What is the market for Lateral Flow Readers/Assay?

The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030.

3. What are the drivers for the Lateral Flow Readers/Assay market?

The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Lateral Flow Readers/Assay market?

Some of the major market key players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

5. Which region has the highest share in the Lateral Flow Readers/Assay market?

1. Lateral Flow Readers/Assay Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Lateral Flow Readers/Assay Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Lateral Flow Readers/Assay Market Key Factors Analysis

5.1. Lateral Flow Readers/Assay Market Drivers
- 5.1.1. Growing instances of infectious diseases
- 5.1.2. Rising cardiovascular disorders
- 5.1.3. Increasing pregnancy diagnostics
- 5.1.4. Rising product developmental activities
5.2. Lateral Flow Readers/Assay Market Restraints and Challenges
- 5.2.1. Challenges in the development of accurate diagnostic tests and equipment
- 5.2.2. Availability of alternative procedure
5.3. Lateral Flow Readers/Assay Market Opportunities
- 5.3.1. Integration of AI and ML for data interpretation
- 5.3.2. Biomarker expansion for early infectious disease detection

6. Lateral Flow Readers/Assay Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Lateral Flow Readers/Assay Market Assessment

7.1. By Product
- 7.1.1. Readers
  - 7.1.1.1. Bench-top Readers
  - 7.1.1.2. Digital/Mobile Readers
- 7.1.2. Kits & Reagents
7.2. By Technique
- 7.2.1. Sandwich Assays
- 7.2.2. Competitive Assays
- 7.2.3. Multiplex Detection Assays
7.3. By Application
- 7.3.1. Clinical Testing
  - 7.3.1.1. Pregnancy Testing
  - 7.3.1.2. Infectious Diseases Testing
  - 7.3.1.3. Cardiac Marker Testing
  - 7.3.1.4. Others
- 7.3.2. Drug Development & Quality Testing
- 7.3.3. Others
7.4. By End-User
- 7.4.1. Hospitals & Clinics
- 7.4.2. Home Care
- 7.4.3. Others
7.5. By Geography
- 7.5.1. North America
  - 7.5.1.1. United States Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.1.2. Canada Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.1.3. Mexico Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
- 7.5.2. Europe
  - 7.5.2.1. France Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.2.2. Germany Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.2.3. United Kingdom Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.2.4. Italy Lateral Flow Readers/Assay market size in USD million (2021-2030)
  - 7.5.2.5. Spain Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.2.6. Rest of Europe Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
- 7.5.3. Asia-Pacific
  - 7.5.3.1. China Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.3.2. Japan Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.3.3. India Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.3.4. Australia Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.3.5. South Korea Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.3.6. Rest of Asia-Pacific Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
- 7.5.4. Rest of the World (RoW)
  - 7.5.4.1. Middle East Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.4.2. Africa Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
  - 7.5.4.3. South America Lateral Flow Readers/Assay Market Size in USD million (2021-2030)

8. Lateral Flow Readers/Assay Market Company and Product Profiles

8.1. Abbott
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Quidel Corporation
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Danaher Corporation
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Siemens Healthineers
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. F. Hoffman-La Roche AG
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. LumiraDx
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. BD
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Eurofins Technologies
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. bioMerieux SA
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Bio-Rad Laboratories, Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Thermo Fisher Scientific
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Hologic, Inc.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. PerkinElmer Inc.
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. QIAGEN
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Merck KGaA
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. OPERON
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Abingdon Health
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. DIALUNOX
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. 3B BlackBio Biotech India Ltd.
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. ADS Biotec Inc.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

簡介目錄圖表

List of Tables

Table 1: Competitive Analysis
Table 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
Table 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
Table 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
Table 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
Table 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
Table 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
Table 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
Table 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
Table 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
Table 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
Table 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
Table 13: Lateral Flow Readers/Assay Market in France (2021-2030)
Table 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
Table 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
Table 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
Table 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
Table 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
Table 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
Table 20: Lateral Flow Readers/Assay Market in China (2021-2030)
Table 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
Table 22: Lateral Flow Readers/Assay Market in India (2021-2030)
Table 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
Table 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
Table 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
Table 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
Table 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
Table 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
Table 29: Lateral Flow Readers/Assay Market in South America (2021-2030)

List of Figures

Figure 1: Competitive Analysis
Figure 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
Figure 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
Figure 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
Figure 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
Figure 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
Figure 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
Figure 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
Figure 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
Figure 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
Figure 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
Figure 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
Figure 13: Lateral Flow Readers/Assay Market in France (2021-2030)
Figure 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
Figure 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
Figure 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
Figure 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
Figure 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
Figure 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
Figure 20: Lateral Flow Readers/Assay Market in China (2021-2030)
Figure 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
Figure 22: Lateral Flow Readers/Assay Market in India (2021-2030)
Figure 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
Figure 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
Figure 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
Figure 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
Figure 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
Figure 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
Figure 29: Lateral Flow Readers/Assay Market in South America (2021-2030)
Figure 30: Market Drivers
Figure 31: Market Barriers
Figure 32: Marker Opportunities
Figure 33: PORTER'S Five Force Analysis